Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Clinical Pharmacology and Therapeutics
|
March 3, 2020
Open Data for Clinical Pharmacology
Jackson Burton, Sanchita Bhattacharya, Klaus Romero, et al.
Mathematical Biosciences
|
June 2, 2012
Disease persistence in epidemiological models: the interplay between vaccination and migration
Jackson Burton, Lora Billings, Derek A T Cummings, et al.
Clinical and Translational Science
|
March 11, 2025
A Tutorial and Use Case Example of the eXtreme Gradient Boosting (XGBoost) Artificial Intelligence Algorithm for Drug Development Applications
Matthew Wiens, Alissa Verone-Boyle, Nick Henscheid, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 11, 2019
Directional inconsistency between Response Evaluation Criteria in Solid Tumors (RECIST) time to progression and response speed and depth
Kaitlyn Johnson, Axel Gomez, Jackson Burton, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 24, 2025
Lower baseline amyloid beta burden is associated with greater percent of amyloid beta positron emission tomography reduction and better clinical outcomes in the aducanumab Phase 3 trials ENGAGE and EMERGE in early Alzheimer's disease
Jackson Burton, Holly M Brothers, R Matthew Hutchison, et al.
Clinical and Translational Science
|
February 1, 2020
Open Data Revolution in Clinical Research: Opportunities and Challenges
Mohamed H Shahin, Sanchita Bhattacharya, Diego Silva, et al.
Therapeutic Innovation & Regulatory Science
|
June 6, 2022
Innovations in Therapy Development for Rare Diseases Through the Rare Disease Cures Accelerator-Data and Analytics Platform
Jane Larkindale, Alexandre Betourne, Amanda Borens, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 8, 2021
Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
Karthik Lingineni, Varun Aggarwal, Juan Francisco Morales, et al.
Clinical Pharmacology and Therapeutics
|
June 12, 2023
Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision
Jackson Burton, Bilal Abuasal, Sagar Bachhav, et al.
Clinical and Translational Science
|
July 24, 2020
Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington's Disease
Ariana P Mullin, Diane Corey, Emily C Turner, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Clinical Pharmacology and Therapeutics
|
March 3, 2020
Open Data for Clinical Pharmacology
Jackson Burton, Sanchita Bhattacharya, Klaus Romero, et al.
Mathematical Biosciences
|
June 2, 2012
Disease persistence in epidemiological models: the interplay between vaccination and migration
Jackson Burton, Lora Billings, Derek A T Cummings, et al.
Clinical and Translational Science
|
March 11, 2025
A Tutorial and Use Case Example of the eXtreme Gradient Boosting (XGBoost) Artificial Intelligence Algorithm for Drug Development Applications
Matthew Wiens, Alissa Verone-Boyle, Nick Henscheid, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 11, 2019
Directional inconsistency between Response Evaluation Criteria in Solid Tumors (RECIST) time to progression and response speed and depth
Kaitlyn Johnson, Axel Gomez, Jackson Burton, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 24, 2025
Lower baseline amyloid beta burden is associated with greater percent of amyloid beta positron emission tomography reduction and better clinical outcomes in the aducanumab Phase 3 trials ENGAGE and EMERGE in early Alzheimer's disease
Jackson Burton, Holly M Brothers, R Matthew Hutchison, et al.
Clinical and Translational Science
|
February 1, 2020
Open Data Revolution in Clinical Research: Opportunities and Challenges
Mohamed H Shahin, Sanchita Bhattacharya, Diego Silva, et al.
Therapeutic Innovation & Regulatory Science
|
June 6, 2022
Innovations in Therapy Development for Rare Diseases Through the Rare Disease Cures Accelerator-Data and Analytics Platform
Jane Larkindale, Alexandre Betourne, Amanda Borens, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 8, 2021
Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
Karthik Lingineni, Varun Aggarwal, Juan Francisco Morales, et al.
Clinical Pharmacology and Therapeutics
|
June 12, 2023
Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision
Jackson Burton, Bilal Abuasal, Sagar Bachhav, et al.
Clinical and Translational Science
|
July 24, 2020
Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington's Disease
Ariana P Mullin, Diane Corey, Emily C Turner, et al.
Page
of 3